Day Two - ET (Eastern Time, GMT-05:00)
Day Two - ET (Eastern Time, GMT-05:00)
- Susan Stein, Patient Advocacy and Engagement Thought Leader
- Benchmark with colleagues on the guardrails that need to be put in place and the processes that need to be updated to catch specialty carve outs
- Understand how the accumulator landscape is changing
- Navigate the varying state laws within the copay ecosystem
- Diana Villanova - Vice President, Patient Support Services Strategy, Mercalis
- Blake Johnson - Vice President, Business Development, Mercalis
- Michael Harris - Vice President, Patient Support Services Strategy, Mercalis
Unlike other departments within a pharmaceutical company, there is no standard way to structure your patient services department. Take a closer look into the gray areas, such as quarterly business reviews (Who attends them? Who reviews agreements and documents) and organizational flow (Who reports to who?) to determine best practices on how to structure your patient services department to fit the needs and goals of your organization.
- Kinshuk Saxena, PharmD, MBA - Lead, Commercialization Strategy, Novartis
- Matt Giordano - Director of Patient Services Field Operations, Krystal Biotech, Inc.
Though especially applicable in the rare disease world, it is essential for patient support programs of all kinds, and for all disease states, to be tailored specifically to the population at hand.
- Understand the different facets that must be considered when designing a curated PSP
- Discuss the value and the impact of a supportive, customized and properly implemented PSP
- Learn how to ensure that patient centricity is found in all aspects of your PSP
- Suzanne Marinakos - Director, Patient Services Operations, Novo Nordisk
- Josh Konetzni - Vice President, Head of Business Development, VMS BioMarketing
- Jennifer Stephenson - Vice President, Head of Client Relations, VMS BioMarketing
- Samara Ashley - Director, Clinical Operations, VMS BioMarketing
- Cheryl Wood - Clinical Nurse Educator, VMS BioMarketing
- Define the roles and responsibilities of compliance within patient support programs
- Identify best practices to work with external stakeholders
- Learn how to develop frameworks that increase patient accessibility whilst maintaining compliance firewalls
- Hear real life examples on executing compliant patient support programs
- Peter Agnoletto - Compliance Officer, General Medicines and Consumer Healthcare, Sanofi
- Donna White - Vice President, Compliance Officer, Chiesi USA Inc.
- Keren Tenenbaum - US General Counsel, Chief Compliance Officer, Ascendis Pharma
- Michelle Anderson - US Commercial Counsel, Alexion AstraZeneca Rare Disease
Falling under a myriad of titles and names, field teams (ie. Nurse educators, field reimbursement, clinical consultant, etc.) are often immeasurably valuable to patients, though there are a number of compliance considerations that must be taken into account in order to mitigate risk. During this session, go back to the basics and uncover the areas of concern that you need to be thinking about, including the use of scripts, what information should or should not be reported to medial and the idea of compensation.
Medication adherence, or the lack thereof, has been a problem at the forefront of every pharmaceutical company’s mind for years. During this session, examine the challenges associated with medication adherence and develop innovative solutions that you can implement within your own PSP to address such challenges. Look at future trends in adherence to remain proactive.
- Snigdha Santra - Director, Business Insights and Strategy, Chugai Pharmaceuticals
- Kirti Patel - Global Medical Governance and Patient Support Programs Lead, Sanofi
- Vanessa Leiva - MAP and Patient Solutions Lead, Roche
With alarming script abandonment rates of 30-60% and meager 20-30% patient engagement in Hub or patient support programs, how can drug manufacturers adapt? Especially in a world shaped by on-the-go lifestyles, technological advancements, COVID-19, and the rise of remote work? Our talk aims to unpack these questions.
- Right vs. Wrong Context: Ever wonder why reaching patients at inopportune moments leads to failed engagement? We'll reveal the specific contexts where SMS or email communications are most effective.
- Unopened Emails & Unanswered Calls: Why do your automated systems miss the mark? Discover the common pitfalls that make these methods ineffective and what you can do differently.
- Prescription "Hotspots": What are the "hotspots" for effective patient engagement and how can you identify them? Get ready for actionable insights.
- Micro-Messaging: Learn why less is more when it comes to digital communications and how this strategy can drastically improve adherence rates.
- Frictionless Fulfillment & Journey Cohesion: We'll share key strategies for ensuring a cohesive patient journey, all without using an app.
- Yishai Knobel - Co-Founder and CEO, RxWare
Patient Privacy within your patient support program ensure safe, legal and trustful health practices, critical for meeting state and federal guidelines.
- Uncover the patient health information that is necessary for your program, and the controls that should be instated surrounding this data
- Understand what constitutes an appropriate interaction with HCPs, as well as the data that can be shared with them
- Tom Hiney - Privacy Counsel, Blueprint Medicines
- Corey Dennis - Former Lead, US Privacy Officer, Sanofi
Key considerations of FRM strategy and go-to-market model.
- Steve Fields - Vice President of Field Access and Reimbursement, Inizio Engage